In silico methods to predict drug toxicity

Current Opinion in Pharmacology

Volumn 13, Issue 5, 2013, Pages 802-806

  Roncaglioni, Alessandra ^a   Toropov, Andrey A ^a   Toropova, Alla P ^a   Benfenati, Emilio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; CARCINOGENICITY; CARDIOTOXICITY; COMPUTER MODEL; COMPUTER PREDICTION; DEVELOPMENTAL TOXICITY; DRUG DISTRIBUTION; DRUG IMPURITY; DRUG METABOLISM; DRUG SCREENING; GENOTOXICITY; LIGAND BINDING; LIVER TOXICITY; MOLECULAR DOCKING; MUTAGENICITY; NEUROTOXICITY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REPRODUCTIVE TOXICITY;

COMPUTER SIMULATION; DRUG EVALUATION, PRECLINICAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; LEGISLATION, DRUG; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS;

EID: 84892978274     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.06.001     Document Type: Review

References (46)

1. Benfenati E (Ed): Theory, guidance and applications on QSAR and REACH. E-book available at: http://www.orchestra-qsar.eu/documents/333.
2. Roncaglioni A, Benfenati E: In silico-aided prediction of biological properties of chemicals: oestrogen receptor-mediated effects. Chem Soc Rev 2008, 37: 441-450.
3. Modi S, Hughes M, Garrow A, White A: The value of in silico chemistry in the safety assessment of chemicals in the consumer goods and pharmaceutical industries. Drug Discov Today 2012, 17: 135-142.
4. Cox PB, Gregg RJ, Vasudevan A: Abbott Physicochemical Tiering (APT)-a unified approach to HTS triage. Bioorg Med Chem 2012, 20: 4564-4573.
5. Jacob A, Pratuangdejkul J, Buffet S, Launay J-M, Manivet P: In silico platform for xenobiotics ADME-T pharmacological properties modeling and prediction. Part II: the body in a Hilbertian space. Drug Discov Today 2009, 14: 406-412.
6. Hou T, Li Y, Zhang W, Wang J: Recent developments of in silico predictions of intestinal absorption and oral bioavailability. Comb Chem High Throughput Screen 2009, 12: 497-506.
7. Wang J, Hou T: Recent advances on aqueous solubility prediction. Comb Chem High Throughput Screen 2011, 14: 328-338.
8. Talevi A, Goodarzi M, Ortiz EV, Duchowicz PR, Bellera CL, Pesce G, Castro EA, Bruno-Blanch LE: Prediction of drug intestinal absorption by new linear and non-linear QSPR. Eur J Med Chem 2011, 46: 218-228.
9. Larregieu CA, Benet LZ: Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements. AAPS J 2013, 15: 483-497.
10. Bahadduri PM, Polli JE, Swaan PW, Ekins S: Targeting drug transporters - combining in silico and in vitro approaches to predict in vivo. Methods Mol Biol 2010, 637: 65-103.
11. Martins IF, Teixeira AL, Pinheiro L, Falcao AO: A Bayesian approach to in silico blood-brain barrier penetration modeling. J Chem Inf Model 2012, 52: 1686-1697.
12. Chen H, Winiwarter S, Fridén M, Antonsson M, Engkvist O: In silico prediction of unbound brain-to-plasma concentration ratio using machine learning algorithms. J Mol Graph Model 2011, 29: 985-995.
13. Li H, Chen Z, Xu X, Sui X, Guo T, Liu W, Zhang J: Predicting human plasma protein binding of drugs using plasma protein interaction QSAR analysis (PPI-QSAR). Biopharm Drug Dispos 2011, 32: 333-342.
14. Kirchmair J, Williamson MJ, Tyzack JD, Tan L, Bond PJ, Bender A, Glen RC: Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms. J Chem Inf Model 2012, 52: 617-648.
15. Moroy G, Martiny VY, Vayer P, Villoutreix BO, Miteva MA: Toward in silico structure-based ADMET prediction in drug discovery. Drug Discov Today 2012, 17: 44-55.
16. Valerio LG Jr, Long A: The in silico prediction of human-specific metabolites from hepatotoxic drugs. Curr Drug Discov Technol 2010, 7: 170-187.
17. Long A: Drug metabolism in silico - the knowledge-based expert system approach. Historical perspectives and current strategies. Drug Discov Today 2013, 10: 147-153.
18. Worth A, Fuart-Gatnik M, Lapenna S, Lo Piparo E, Mostrag-Szlichtyng A, Serafimova R: The Use of Computational Methods in the Toxicological Assessment of Chemicals in Food: Current Status and Future Prospects, Scientific and Technical Research Series EUR 24748 EN. Luxembourg: Publications Office of the European Union; 2011, http://dx.doi.org/10.2788/6234.
19. Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, Lee PW, Tang Y: admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model 2012, 52: 3099-3105.
20. Kortagere S, Ekins S: Troubleshooting computational methods in drug discovery. J Pharm Toxicol Methods 2010, 61: 67-75.
21. Cao D, Wang J, Zhou R, Li Y, Yu H, Hou T: ADMET evaluation in drug discovery, 11 PharmacoKinetics Knowledge Base (PKKB): a comprehensive database of pharmacokinetic and toxic properties for drugs. J Chem Inf Model 2012, 52: 1132-1137.
22. Hosea NA, Jones HM: Predicting pharmacokinetic profiles using in silico derived parameters. Mol Pharm 2013, 10: 1207-1215.
23. Malmborg JJ, Ploeger BA: Predicting human exposure of active drug after oral prodrug administration, using a joined in vitro/ in silico-in vivo extrapolation and physiologically-based pharmacokinetic modeling approach. J Pharmacol Toxicol Methods 2013, 67: 129-214.
24. Kar S, Kunal Roy K: Predictive toxicology using QSAR: a perspective. J Indian Chem Soc 2010, 87: 1455-1515.
25. Kar S, Roy K: Development and validation of a robust model for prediction of carcinogenicity of drugs. Indian J Biochem Biophys 2011, 48: 111-122.
26. Bakhtyari NG, Raitano G, Benfenati E, Martin T, Young D: Comparison of in silico models for prediction of mutagenicity. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2013, 31: 45-66.
27. Milan C, Schifanella O, Roncaglioni A, Benfenati E: Comparison and possible use of in silico tools for carcinogenicity within REACH legislation. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2011, 29: 300-323.
28. Hillebrecht A, Muster W, Brigo A, Kansy M, Weiser T, Singer T: Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitations. Chem Res Toxicol 2011, 24: 843-854.
29. Diaz Ochoa JG, Bucher J, Péry ARR, Zaldivar Comenges JM, Niklas J, Mauch K: A multi-scale modeling framework for individualized, spatiotemporal prediction of drug effects and toxicological risk. Front Pharmacol 2013, 3:204 http://dx.doi.org/10.3389/fphar.2012.00204.
30. Frid AA, Matthews EJ: Prediction of drug-related cardiac adverse effects in humans-B: use of QSAR programs for early detection of drug-induced cardiac toxicities. Regul Toxicol Pharm 2010, 56: 276-289.
31. Huang LC, Wu X, Chen JY: Predicting adverse side effects of drugs. BMC Genomics 2011, 12(Suppl. 5):S11 http://dx.doi.org/10.1186/1471-2164-12-S5-S11.
32. Myshkin E, Brennan R, Khasanova T, Sitnik T, Serebriyskaya T, Litvinova E, Guryanov A, Nikolsky Y, Nikolskaya T, Bureeva S: Prediction of organ toxicity endpoints by QSAR modeling based on precise chemical-histopathology annotations. Chem Biol Drug Des 2012, 80: 406-416.
33. Choi SS, Kim JS, Valerio LG Jr, Sadrieh N: In silico modeling to predict drug-induced phospholipidosis. Toxicol Appl Pharmacol 2013, 269: 195-204.
34. Cheng F, Li W, Wang X, Zhou Y, Wu Z, Shen J, Tang Y: Adverse drug events: database construction and in silico prediction. J Chem Inf Model 2013 http://dx.doi.org/10.1021/ci4000079. (March 22).
35. Vedani A, Dobler M, Smieško M: VirtualToxLab - a platform for estimating the toxic potential of drugs, chemicals and natural products. Toxicol Appl Pharmacol 2012, 261: 142-153.
36. Dobo KL, Greene N, Fred C, Glowienke S, Harvey JS, Hasselgren C, Jolly R, Kenyon MO, Munzner JB, Muster W et al.: In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: An industry survey. Regul Toxicol Pharmacol 2012, 62: 449-455.
37. Contrera JF: Improved in silico prediction of carcinogenic potency (TD50) and the risk specific dose (RSD) adjusted threshold of toxicological concern (TTC) for genotoxic chemicals and pharmaceutical impurities. Regul Toxicol Pharmacol 2011, 59: 133-141.
38. Valerio LG Jr, Cross KP: Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities. Toxicol Appl Pharmacol 2012, 260: 209-221.
39. Bercu JP, Morton SM, Deahl JT, Gombar VK, Callis CM, van Lier RB: In silico approaches to predicting cancer potency for risk assessment of genotoxic impurities in drug substances. Regul Toxicol Pharmacol 2010, 57: 300-306.
40. Briggs K, Cases M, Heard DJ, Pastor M, Pognan F, Sanz F, Schwab CH, Steger-Hartmann T, Sutter A, Watson DK, Wichard JD: Inroads to predict in vivo toxicology - an introduction to the eTOX project. Int J Mol Sci 2012, 13: 3820-3846.
41. Ferrari T, Gini G, Bakhtyari NG, Benfenati E: Mining toxicity structural alerts from SMILES: a new way to derive structure activity relationships. In Proceedings IEEE Symposium Series on Computational Intelligence; Paris, France, IEEE Computational Intelligence Society, Piscataway, NJ, April 11-15: 2011: 120-127.
42. Hardy B, Apic G, Carthew P, Clark D, Cook D, Dix I, Escher S, Hastings J, Heard DJ, Jeliazkova N et al.: Toxicology ontology perspectives. ALTEX 2012, 29: 139-156.
43. Zhou W, Huang C, Li Y, Duan J, Wang Y, Yang L: A systematic identification of multiple toxin-target interactions based on chemical, genomic and toxicological data. Toxicology 2012, 304: 173-184.
44. Toropov AA, Toropova AP, Raska I Jr, Benfenati E, Gini G: QSAR modeling of endpoints for peptides which is based on representation of the molecular structure by a sequence of amino acids. Struct Chem 2012, 23: 1891-1904.
45. Toropov AA, Toropova AP, Benfenati E, Leszczynska D, Leszczynski J: SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations. J Comput Chem 2010, 31: 381-392.
46. Toropov AA, Toropova AP, Benfenati E, Gini G, Puzyn T, Leszczynska D, Leszczynski J: Novel application of the CORAL software to model cytotoxicity of metal oxide nanoparticles to bacteria Escherichia coli. Chemosphere 2012, 89: 1098-1102.